Unveiling 4 Analyst Insights On Celldex Therapeutics
Unveiling 4 Analyst Insights On Celldex Therapeutics
公佈關於Celldex療法的4項分析師見解
In the latest quarter, 4 analysts provided ratings for Celldex Therapeutics (NASDAQ:CLDX), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，4位分析師爲Celldex Therapeutics（納斯達克股票代碼：CLDX）提供了評級，顯示了看漲和看跌的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.25, a high estimate of $90.00, and a low estimate of $67.00. This current average has increased by 10.07% from the previous average price target of $72.00.
分析師分析的12個月目標股價提供了見解，平均目標價爲79.25美元，最高估計爲90.00美元，低估值爲67.00美元。目前的平均價格較之前的平均目標價72.00美元上漲了10.07％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
An in-depth analysis of recent analyst actions unveils how financial experts...
對分析師近期行爲的深入分...
登入免費觀看全文
登入/註冊